BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

770 related articles for article (PubMed ID: 32244558)

  • 1. Diabetes Mellitus and Cardiovascular Risk Assessment in Mothers with a History of Gestational Diabetes Mellitus Based on Postpartal Expression Profile of MicroRNAs Associated with Diabetes Mellitus and Cardiovascular and Cerebrovascular Diseases.
    Hromadnikova I; Kotlabova K; Dvorakova L; Krofta L
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A History of Preterm Delivery Is Associated with Aberrant Postpartal MicroRNA Expression Profiles in Mothers with an Absence of Other Pregnancy-Related Complications.
    Hromadnikova I; Kotlabova K; Krofta L
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postnatal Expression Profile of microRNAs Associated with Cardiovascular and Cerebrovascular Diseases in Children at the Age of 3 to 11 Years in Relation to Previous Occurrence of Pregnancy-Related Complications.
    Hromadnikova I; Kotlabova K; Dvorakova L; Krofta L; Sirc J
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Vascular Endothelial Function in Young and Middle-Aged Women with Respect to a History of Pregnancy, Pregnancy-Related Complications, Classical Cardiovascular Risk Factors, and Epigenetics.
    Hromadnikova I; Kotlabova K; Dvorakova L; Krofta L
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postpartum profiling of microRNAs involved in pathogenesis of cardiovascular/cerebrovascular diseases in women exposed to pregnancy-related complications.
    Hromadnikova I; Kotlabova K; Dvorakova L; Krofta L
    Int J Cardiol; 2019 Sep; 291():158-167. PubMed ID: 31151766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gestational hypertension, preeclampsia and intrauterine growth restriction induce dysregulation of cardiovascular and cerebrovascular disease associated microRNAs in maternal whole peripheral blood.
    Hromadnikova I; Kotlabova K; Hympanova L; Krofta L
    Thromb Res; 2016 Jan; 137():126-140. PubMed ID: 26632513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular and Cerebrovascular Disease Associated microRNAs Are Dysregulated in Placental Tissues Affected with Gestational Hypertension, Preeclampsia and Intrauterine Growth Restriction.
    Hromadnikova I; Kotlabova K; Hympanova L; Krofta L
    PLoS One; 2015; 10(9):e0138383. PubMed ID: 26394310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular Disease-Associated MicroRNAs as Novel Biomarkers of First-Trimester Screening for Gestational Diabetes Mellitus in the Absence of Other Pregnancy-Related Complications.
    Hromadnikova I; Kotlabova K; Krofta L
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First Trimester Prediction of Preterm Delivery in the Absence of Other Pregnancy-Related Complications Using Cardiovascular-Disease Associated MicroRNA Biomarkers.
    Hromadnikova I; Kotlabova K; Krofta L
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substantially Altered Expression Profile of Diabetes/Cardiovascular/Cerebrovascular Disease Associated microRNAs in Children Descending from Pregnancy Complicated by Gestational Diabetes Mellitus-One of Several Possible Reasons for an Increased Cardiovascular Risk.
    Hromadnikova I; Kotlabova K; Dvorakova L; Krofta L; Sirc J
    Cells; 2020 Jun; 9(6):. PubMed ID: 32604801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First trimester prediction models for small-for- gestational age and fetal growth restricted fetuses without the presence of preeclampsia.
    Hromadnikova I; Kotlabova K; Krofta L
    Mol Cell Probes; 2023 Dec; 72():101941. PubMed ID: 37951512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating early- and mid-pregnancy microRNAs and risk of gestational diabetes.
    Wander PL; Boyko EJ; Hevner K; Parikh VJ; Tadesse MG; Sorensen TK; Williams MA; Enquobahrie DA
    Diabetes Res Clin Pract; 2017 Oct; 132():1-9. PubMed ID: 28783527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of cardiovascular and cerebrovascular disease associated microRNA expression in umbilical cord blood in gestational hypertension, preeclampsia and fetal growth restriction.
    Hromadnikova I; Kotlabova K; Ivankova K; Vedmetskaya Y; Krofta L
    Int J Cardiol; 2017 Dec; 249():402-409. PubMed ID: 29121743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-Trimester Screening for Fetal Growth Restriction and Small-for-Gestational-Age Pregnancies without Preeclampsia Using Cardiovascular Disease-Associated MicroRNA Biomarkers.
    Hromadnikova I; Kotlabova K; Krofta L
    Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-Trimester Screening for Miscarriage or Stillbirth-Prediction Model Based on MicroRNA Biomarkers.
    Hromadnikova I; Kotlabova K; Krofta L
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular Disease-Associated MicroRNA Dysregulation during the First Trimester of Gestation in Women with Chronic Hypertension and Normotensive Women Subsequently Developing Gestational Hypertension or Preeclampsia with or without Fetal Growth Restriction.
    Hromadnikova I; Kotlabova K; Krofta L
    Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Analysis in Young and Middle-Aged Mothers-Relation between Expression of Cardiovascular Disease Associated MicroRNAs and Abnormal Clinical Findings.
    Hromadnikova I; Kotlabova K; Krofta L
    J Pers Med; 2021 Jan; 11(1):. PubMed ID: 33440716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Analysis in Children Born from Normal and Complicated Pregnancies-Cardiovascular Disease Associated microRNAs and the Incidence of Prehypertension/Hypertension, Overweight/Obesity, Valve Problems and Heart Defects.
    Hromadnikova I; Kotlabova K; Krofta L; Sirc J
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased Expression of Circulating miR-20a-5p in South African Women with Gestational Diabetes Mellitus.
    Pheiffer C; Dias S; Rheeder P; Adam S
    Mol Diagn Ther; 2018 Jun; 22(3):345-352. PubMed ID: 29556924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unhealthy Levels of Phthalates and Bisphenol A in Mexican Pregnant Women with Gestational Diabetes and Its Association to Altered Expression of miRNAs Involved with Metabolic Disease.
    Martínez-Ibarra A; Martínez-Razo LD; Vázquez-Martínez ER; Martínez-Cruz N; Flores-Ramírez R; García-Gómez E; López-López M; Ortega-González C; Camacho-Arroyo I; Cerbón M
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.